Soluble ST2 and risk of cognitive impairment after acute ischemic stroke: A prospective observational study
Soluble ST2 and risk of cognitive impairment after acute ischemic stroke: A prospective observational study
Soluble suppression of tumorigenesis-2 (sST2) was reported to be associated with cognitive performance and risk of incident stroke. However, the impact of sST2 on cognitive function after ischemic stroke is unclear. We aimed to assess the association of sST2 and cognitive impairment at 3 months in acute ischemic stroke patients.
Thể loại
Tài liệu miễn phí Sức khỏe người cao tuổi